CG WG Call Notes leading to 2014 January WGM

Proposed Agenda

• Update on the Global Alliance by Gil

Attendees

• Amnon Shabo, Siew Lam, Ruby Russell, Grant Wood, Scott Bolte, Lloyd, Phil, Chris Pack, Mollie, Larry

Proposed Agenda

• Update on the Global Alliance by Gil

Attendees

• Amnon Shabo, Siew Lam, Gil Alterovitz, Ruby Russell, Grant Wood, Scott Bolte

Draft Minutes

• Discussed the correspondence of Scott, Lloyd and Kevin on Family History and FHIR

Proposed Agenda

• Discuss the CG DIM project

Attendees

• Amnon Shabo, Siew Lam, Grant Wood, Gil Alterovitz, Mollie, Phil Pochon, Yan Heras

Draft Minutes

• Amnon went through a slide deck, each containing a model underlying one of the specs developed by the HL7 Clinical Genomics group, and then presented a sketch of thought on where we could go with the DIM

Proposed Agenda

• Discuss the revised Project Scope Statement of CG Domain Information Model(s)
  • See discussion on modeling issues at the project wiki page: http://wiki.hl7.org/index.php?title=Clinical_Genomics_Domain_Information_Model(s)_Project#Modeling_Discussion

• Need to submit the Cambridge WGM Meeting Minutes by the end of this week

• Change of WGM schedule
  • From Wednesday & Thursday to Tuesday & Wednesday
  • Do we need all session in both days?
    • Accommodates joints with AP and OO with solo meetings before the joints
    • So far we had a day and a half
    • We could run from Tuesday Q2 to Wednesday Q3

Attendees

• Amnon Shabo, Siew Lam, Grant Wood, Larry Babb, Gil Alterovitz, Jenny, Ruby Russell, Mollie

Draft Minutes

• Grant will start the Cambridge WGM minutes by inserting the attendees in each session; Amnon will add to it minutes as he can recall and send out to the mailing list so that people can add to it
• Discussed the revisions to the CG DIM PSS and hearing no objections decided to resubmit to DESD
• Discussed initial modeling considerations of the DIM
• Amnon brought up the GTR, v2, v3 and FHIR models and made comments on the current differences
• Is research use case part of the DIM?
• Mollie said it should be clinically oriented with transnational capabilities at the most
• Amnon said it's Universal in the sense that we start from common denominator and then allow each environment to constrain it as need; e.g., for clinical it should be highly constrained